|
9th Annual Pharma Project & Portfolio Management conference to be held on February 4, 5 & 6, 2026, in Goa
|
|
Our Bureau, Mumbai
December 15 , 2025
|
|
|
The pharmaceutical industry stands at a decisive moment where science, technology, and strategy must converge to unlock true value. As the global market becomes more complex, driven by biologics, digital transformation, evolving regulations, and geopolitical uncertainty, there is an urgent need for smarter ways to prioritize portfolios and manage projects that deliver measurable outcomes.
Addressing this need, the Pharma Project & Portfolio Management conference returns as one of the industry’s most anticipated platforms for senior leaders, innovators, and execution experts to come together under one roof.
Scheduled on February 4, 5, and 6, 2026, in Goa, this flagship programme, organized by Eminence Business Media, will bring together portfolio and project management leaders, R&D strategists, PMOs, digital transformation champions, and investment decision-makers from India and abroad. The three-day programme is designed to provide a 360-degree view of how pharma organizations can seamlessly connect vision with execution, and strategy with impact.
The 2026 edition is structured around three focused themes, each day exploring a critical dimension of modern pharmaceutical management:
Day 1: Portfolio Management Excellence
Dedicated to strategic foresight and decision-making, day 1 will focus on how organizations can build agile, innovation-ready portfolios. Sessions will explore molecule selection frameworks, portfolio ROI measurement, IP foresight, and governance models that balance short-term wins with long-term growth. Delegates will participate in simulation labs and fishbowl-style governance debates that translate data and strategy into actionable insights.
Day 2: Integrated Portfolio & Project Strategy
Day 2 bridges strategy and delivery. Expect discussions on digital PMOs, CapEx optimization, and managing interdependencies across programmes that connect R&D, manufacturing, and commercialization. With geopolitical shifts and regulatory evolution shaping business priorities, the day also covers supply chain resilience, resource orchestration, and data-driven decision-making. Case study labs and interactive polls will make each session immersive and outcome-oriented.
Day 3: Project Management Mastery
The final day focuses on execution excellence, how disciplined, data-driven, and emotionally intelligent leadership can transform outcomes. Topics include predictive risk management (Project Risk 4.0), change management in digital PMOs, AI-driven idea enablement, and leadership workshops that simulate real-world project pressures. The day concludes with a powerful CXO panel on the evolving identity of the ‘Future Project Manager- Adaptive, Analytical, Accountable.’
The conference promises more than content, it promises transformation. Participants can expect:
• Real-world insights through practical case studies, demonstrations, and leadership dialogues.
• Interactive learning via workshops, simulation games, and gamified sessions that move beyond theory.
• Strategic networking with senior decision-makers, solution providers, and thought leaders shaping the future of pharma.
• Actionable takeaways in governance, risk management, portfolio optimization, and digital transformation.
Each session is curated to spark new thinking and help delegates redefine performance benchmarks for their organizations. Whether your focus is research, operations, automation, or business transformation, it offers an unparalleled opportunity to strengthen strategic agility and execution excellence.
To be part of India’s most influential platform dedicated to advancing pharmaceutical project and portfolio management, visit Website: www.pharmaprojectandportfolio.com.
For registration and participation, contact Shravan Nair at shravan@eminencemedia.in
|
|
|
|
|
|
|
|
TOPICS
|
The Food and Drug Administration (FDA), Maharashtra, has issued a public advisory urging citizens to report any misleadi ...
|
|
|
|
|